Download PDF
Thromb Haemost 2011; 105(06): 1032-1045
DOI: 10.1160/TH11-01-0029
Platelets and Blood Cells
Schattauer GmbH

A novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesis

Dongying Ma   *
1   Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
,
Xueqing Xu   *
2   Vector Biology Section Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
,
Su An   *
1   Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
4   School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China
,
Huan Liu
1   Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
,
Xuening Yang
3   Malaria Genetics Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
,
John F. Andersen
2   Vector Biology Section Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
,
Yipeng Wang
1   Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
,
Fuyuki Tokumasu
3   Malaria Genetics Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
,
José M. C. Ribeiro
2   Vector Biology Section Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
,
Ivo M. B. Francischetti
2   Vector Biology Section Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
,
Ren Lai
1   Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
› Author Affiliations
Further Information

Publication History

Received: 18 January 2011

Accepted after major revision: 08 February 2011

Publication Date:
28 November 2017 (online)

Also available at
    Permissions and Reprints

Summary

A novel family of RGD-containing molecules (Tablysin-15) has been molecularly characterised from the salivary gland of the haematophagous horsefly Tabanus yao. Tablysin-15 does not share primary sequence homology to any disintegrin discovered so far, and displays an RGD motif in the N-terminus of the molecule. It is also distinct from disintegrins from Viperidae since its mature form is not released from a metalloproteinase precursor. Tablysin-15 exhibits high affinity binding for platelet αIIbβ3 and endothelial cell αVβ3 integrins, but not for α5β1 or α2β1. Accordingly, it blocks endothelial cell adhesion to vitronectin (IC50 ~1 nM) and marginally to fibronectin (IC50 ~1 μM), but not to collagen. It also inhibits fibroblast growth factor (FGF)-induced endothelial cell proliferation, and attenuates tube formation in vitro. In platelets, Tablysin-15 inhibits aggregation induced by collagen, ADP and convulxin, and prevents static platelet adhesion to immobilised fibrinogen. In addition, solid-phase assays and flow cytometry demonstrates that αIIbβ3 binds to Tablysin-15. Moreover, immobilised Tablysin-15 supports platelet adhesion by a mechanism which was blocked by anti-integrin αIIbβ3 monoclonal antibody (e.g. abciximab) or by EDTA. Furthermore, Tablysin-15 dose-dependently attenuates thrombus formation to collagen under flow. Consistent with these findings, Tablysin-15 displays antithrombotic properties in vivo suggesting that it is a useful tool to block αIIbβ3, or as a prototype to develop antithrombotics. The RGD motif in the unique sequence of Tablysin-15 represents a novel template for studying the structure-function relationship of the disintegrin family of inhibitors.

Keywords

Haematophagy - blood-sucking - disintegrin - thrombosis - sialogenins

* These authors contributed equally to this paper.


 

  • References

  • 1 Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008; 8: 604-617.
    CrossrefPubMedGoogle Scholar
  • 2 Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100.
    CrossrefPubMedGoogle Scholar
  • 3 Zannetti A, Del Vecchio S, Iommelli F. et al. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5). Clin Cancer Res 2009; 15: 5224-5233.
    CrossrefPubMedGoogle Scholar
  • 4 Huang TF. What have snakes taught us about integrins?. Cell Mol Life Sci 1998; 54: 527-540.
    CrossrefPubMedGoogle Scholar
  • 5 Markland FS. Snake venoms and the hemostatic system. Toxicon 1998; 36: 1749-1800.
    CrossrefPubMedGoogle Scholar
  • 6 Calvete JJ. Structure-function correlations of snake venom disintegrins. Curr Pharm Des 2005; 11: 829-835.
    CrossrefPubMedGoogle Scholar
  • 7 Rahman S, Flynn G, Aitken A. et al. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery. Biochem J 2000; 345: 701-709.
    CrossrefPubMedGoogle Scholar
  • 8 Lu X, Lu D, Scully MF. et al. Structure-activity relationship studies on ADAM protein-integrin interactions. Cardiovasc Hematol Agents Med Chem 2007; 5: 29-42.
    CrossrefPubMedGoogle Scholar
  • 9 Sanz L, Bazaa A, Marrakchi N. et al. Molecular cloning of disintegrins from Cerastes vipera and Macrovipera lebetina transmediterranea venom gland cDNA libraries: insight into the evolution of the snake venom integrin-inhibition system. Biochem J 2006; 395: 385-392.
    CrossrefPubMedGoogle Scholar
  • 10 Fox JW, Serrano SM. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J 2008; 275: 3016-3030.
    CrossrefPubMedGoogle Scholar
  • 11 Kini RM, Evans HJ. Structural domains in venom proteins: evidence that metal-loproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 1992; 30: 265-293.
    CrossrefPubMedGoogle Scholar
  • 12 Watson SP, Auger JM, McCarty OJ. et al. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 2005; 3: 1752-1762.
    CrossrefPubMedGoogle Scholar
  • 13 Ludwig IS, Geijtenbeek TB, van Kooyk Y. Two way communication between neutrophils and dendritic cells. Curr Opin Pharmacol 2006; 6: 408-413.
    CrossrefPubMedGoogle Scholar
  • 14 Silva R, D’Amico G, Hodivala-Dilke KM. et al. Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol 2008; 28: 1703-1713.
    CrossrefPubMedGoogle Scholar
  • 15 Jackson SP, Schoenwaelder SM. Antiplatelet therapy: in search of the ‘magic bullet‘. Nat Rev Drug Discov 2003; 2: 775-789.
    CrossrefPubMedGoogle Scholar
  • 16 McLane MA, Marcinkiewicz C, Vijay-Kumar S. et al. Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med 1998; 219: 109-119.
    CrossrefPubMedGoogle Scholar
  • 17 Swenson S, Ramu S, Markland FS. Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr Pharm Des 2007; 13: 2860-2871.
    CrossrefPubMedGoogle Scholar
  • 18 Francischetti IM. Platelet aggregation inhibitors from hematophagous animals. Toxicon 2010; 56: 1130-1144.
    CrossrefPubMedGoogle Scholar
  • 19 Ribeiro JM, Francischetti IM. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu Rev Entomol 2003; 48: 73-88.
    CrossrefPubMedGoogle Scholar
  • 20 Francischetti IM, Sa-Nunes A, Mans BJ. et al. The role of saliva in tick feeding. Front Biosci 2009; 14: 2051-2088.
    PubMedGoogle Scholar
  • 21 Mans BJ, Louw AI, Neitz AW. Savignygrin, a platelet aggregation inhibitor from the soft tick Ornithodoros savignyi, presents the RGD integrin recognition motif on the Kunitz-BPTI fold. J Biol Chem 2002; 277: 21371-21378.
    CrossrefPubMedGoogle Scholar
  • 22 Wang X, Coons LB, Taylor DB. et al. Variabilin, a novel RGD-containing antagonist of glycoprotein IIb-IIIa and platelet aggregation inhibitor from the hard tick Dermacentor variabilis. J Biol Chem 1996; 271: 17785-17790.
    CrossrefPubMedGoogle Scholar
  • 23 Mazur P, Henzel WJ, Seymour JL. et al. Ornatins: potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata. Eur J Biochem 1991; 202: 1073-1082.
    CrossrefPubMedGoogle Scholar
  • 24 McLane MA, Gabbeta J, Rao AK. et al. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function. Thromb Haemost 1995; 74: 1316-1322.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Xu X, Yang H, Ma D. et al. Toward an understanding of the molecular mechanism for successful blood feeding by coupling proteomics analysis with pharmacological testing of horsefly salivary glands. Mol Cell Proteomics 2008; 7: 582-590.
    CrossrefPubMedGoogle Scholar
  • 26 Ma D, Wang Y, Yang H. et al. Anti-thrombosis repertoire of blood-feeding horsefly salivary glands. Mol Cell Proteomics 2009; 8: 2071-2079.
    CrossrefPubMedGoogle Scholar
  • 27 Francischetti IM, Saliou B, Leduc M. et al. Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets. Toxicon 1997; 35: 1217-1228.
    CrossrefPubMedGoogle Scholar
  • 28 Calvo E, Tokumasu F, Marinotti O. et al. Aegyptin, a novel mosquito salivary gland protein, specifically binds to collagen and prevents its interaction with platelet glycoprotein VI, integrin alpha2beta1, and von Willebrand factor. J Biol Chem 2007; 282: 26928-26938.
    CrossrefPubMedGoogle Scholar
  • 29 Quinn M, Deering A, Stewart M. et al. Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists. Circulation 1999; 99: 2231-2238.
    CrossrefPubMedGoogle Scholar
  • 30 Chang SJ, Chang CN, Chen CW. Occupancy of glycoprotein IIb/IIIa by B-6 vitamers inhibits human platelet aggregation. J Nutr 2002; 132: 3603-3606.
    CrossrefPubMedGoogle Scholar
  • 31 Francischetti IM, Mather TN, Ribeiro JM. Tick saliva is a potent inhibitor of endothelial cell proliferation and angiogenesis. Thromb Haemost 2005; 94: 167-174.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Assumpcao TC, Alvarenga PH, Ribeiro JM. et al. Dipetalodipin, a novel multi-functional salivary lipocalin that inhibits platelet aggregation, vasoconstriction, and angiogenesis through unique binding specificity for TXA2, PGF2alpha, and 15(S)-HETE. J Biol Chem 2010; 285: 39001-39012.
    CrossrefPubMedGoogle Scholar
  • 33 Sperzel M, Huetter J. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. J Thromb Haemost 2007; 5: 2113-2118.
    CrossrefPubMedGoogle Scholar
  • 34 Dejana E, Villa S, de Gaetano G. Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost 1982; 48: 108-111.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Subramaniam M, Frenette PS, Saffaripour S. et al. Defects in hemostasis in P-selectin-deficient mice. Blood 1996; 87: 1238-1242.
    PubMedGoogle Scholar
  • 36 Seymour JL, Henzel WJ, Nevins B. et al. Decorsin. A potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J Biol Chem 1990; 265: 10143-10147.
    PubMedGoogle Scholar
  • 37 Gould RJ, Polokoff MA, Friedman PA. et al. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 1990; 195: 168-171.
    CrossrefPubMedGoogle Scholar
  • 38 Blobel CP, White JM. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol 1992; 4: 760-765.
    CrossrefPubMedGoogle Scholar
  • 39 Scarborough RM, Rose JW, Naughton MA. et al. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 1993; 268: 1058-1065.
    PubMedGoogle Scholar
  • 40 Assumpcao TC, Charneau S, Santiago PB. et al. Insight into the Salivary Transcriptome and Proteome of Dipetalogaster maxima. J Proteome Res 2011; 10: 1669-1679.
    PubMedGoogle Scholar
  • 41 Faili A, Randon J, Francischetti IM. et al. Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway. Biochem J 1994; 298: 87-91.
    CrossrefPubMedGoogle Scholar
  • 42 Clemetson KJ, Kini RM. Introduction. Toxins and Hemostasis. From bench to bedside. Springer; 2010. pp. 1-9.
    Google Scholar
  • 43 Cheresh DA, Stupack DG. Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 2008; 27: 6285-6298.
    CrossrefPubMedGoogle Scholar
  • 44 Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010; 11: 288-300.
    CrossrefPubMedGoogle Scholar
  • 45 Griffioen AW, Vyth-Dreese FA. Angiostasis as a way to improve immunotherapy. Thromb Haemost 2009; 101: 1025-1031.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 46 Marcinkiewicz C. Functional characteristic of snake venom disintegrins: potential therapeutic implication. Curr Pharm Des 2005; 11: 815-827.
    CrossrefPubMedGoogle Scholar
  • 47 Munnix IC, Cosemans JM, Auger JM. et al. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009; 102: 1149-1156.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Watson SP. Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des 2009; 15: 1358-1372.
    CrossrefPubMedGoogle Scholar
  • 49 Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009; 102: 248-257.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Francischetti IM, Seydel KB, Monteiro RQ. Blood coagulation, inflammation, and malaria. Microcirculation 2008; 15: 81-107.
    CrossrefPubMedGoogle Scholar